The objective of this project is to elucidate the interindividual variations in excretion of curcumin and its metabolites.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
8
subjects will be assigned to consume one capsule of curcumin (330 mg of curcumin per capsule) three times a day (one capsule with each meal).
Institute for Applied Life Sciences
Amherst, Massachusetts, United States
Determine the concentration of curcumin and its metabolites in the human fecal samples.
Utilize LC-MSMS to identify and quantify the curcumin and its metabolites in the subjects fecal samples.
Time frame: 3-4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.